Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium

Vaccine

Volumn 32, Issue 46, 2014, Pages 6075-6083

  Blommaert, Adriaan ^a,b   Bilcke, Joke ^a   Vandendijck, Yannick ^b   Hanquet, Germaine ^c   Hens, Niel ^a,b   Beutels, Philippe ^a,d  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c BELGIAN HEALTH CARE KNOWLEDGE CENTRE KCE   (Belgium)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cost utility; Elderly; Flu; Immunocompromised; Pregnancy; Risk groups; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; COST EFFECTIVENESS ANALYSIS; FATALITY; FEMALE; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; INFLUENZA VACCINATION; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; NEWBORN PERIOD; PHYSICIAN; PREGNANT WOMAN; QUALITY ADJUSTED LIFE YEAR; SEASONAL INFLUENZA; SECONDARY INFECTION; SENSITIVITY ANALYSIS; VACCINATION; BELGIUM; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH SERVICE; INFLUENZA, HUMAN; PREGNANCY; STATISTICAL MODEL;

BELGIUM; COST-BENEFIT ANALYSIS; FEMALE; HEALTH PERSONNEL; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, ECONOMIC; PREGNANCY; QUALITY-ADJUSTED LIFE YEARS; VACCINATION;

EID: 84907989669     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.08.085     Document Type: Article

References (41)

1. Hanquet G., Jonckheer P., Vlayen J., Vrijens F., Thiry N., Beutels P. Seasonal influenza vaccination: priority target groups - part 1. Good Clinical Practice (GCP) 2011, Belgian Health Care Knowledge Centre (KCE), Brussels, KCE Reports 162C. D/2011/10.273/45, http://www.kce.fgov.be/publication/report/seasonal-influenza-vaccination-priority-target-groups-%E2%80%93-part-i.
2. Belgian Health Council Vaccination contre la grippe saisonnière Saison hivernale 2010-2011 2010, September, 8682. Belgian Health Council, Brussels.
3. Beutels P., Vandendijck Y., Willem L., Goeyvaerts N., Blommaert A., Van Kerckhove K., et al. Seasonal influenza vaccination: prioritizing children or other target groups? Part II: cost-effectiveness analysis 2013, Belgian Health Care Knowledge Centre (KCE), Brussels, KCE Reports 204S2.D/2013/10.273/47, http://www.kce.fgov.be/publication/report/seasonal-influenza-vaccination-prioritizing-children-or-other-target-groups-part-.
4. Jefferson T. Influenza vaccination: policy versus evidence. BMJ 2006, 333:912-915.
5. Beigi R.H., Wiringa A.E., Bailey R.R., Assi T.-M., Lee B.Y. Economic value of seasonal and pandemic influenza vaccination during pregnancy. Clin Infect Dis 2009, 49:1784-1792.
6. Jit M., Cromer D., Baguelin M., Stowe J., Andrews N., Miller E. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales. Vaccine 2010, 29:115-122.
7. Myers E.R., Misurski D.A., Swamy G.K. Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy. Am J Obstet Gynecol 2011, 204:S128-S140.
8. Festini F., Biermann K.P., Neri S., Reali M.F., de Martino M. Influenza vaccination of nurses in an Italian pediatric hospital: effects on absenteeism and on costs, factors associated with vaccine uptake and analysis of personal motivations. A prospective cohort study. Assist Inferm Ric 2007, 26:5-13.
9. Dutheil F., Delaire P., Boudet G., Rouffiac K., Djeriri K., Souweine B., et al. Cost/effectiveness comparison of the vaccine campaign and reduction of sick leave, after vaccination against influenza among the Clermont-Ferrand University Hospital staff. Med Mal Infect 2008, 38:567-573.
10. Colombo G.L., Ferro A., Vinci M., Zordan M., Serra G. Cost-benefit analysis of influenza vaccination in a public healthcare unit. Ther Clin Risk Manage 2006, 2:219-226.
11. Chicaiza-Becerra L.A., Garcia-Molina M., Ballesteros M., Gamboa O., Diaz J., Vega R. Economic evaluation of influenza vaccine applied to health personnel attending hospitalised oncological patients. Rev Salud Publica (Bogota) 2008, 10:756-766.
12. Abbott K.C., Yuan C.M., Lee J.L. Nothing to sneeze at: efficacy and cost-effectiveness of the influenza vaccine in patients receiving long-term dialysis. Am J Kidney Dis 2011, 57:651-653.
13. Lee B.Y., Stalter R.M., Bacon K.M., Tai J.H., Bailey R.R., Zimmer S.M., et al. Cost-effectiveness of adjuvanted versus nonadjuvanted influenza vaccine in adult hemodialysis patients. Am J Kidney Dis 2011, 57:724-732.
14. Nosyk B., Sharif B., Sun H., Cooper C., Anis A.H. The cost-effectiveness and value of information of three influenza vaccination dosing strategies for individuals with human immunodeficiency virus. PLoS ONE 2011, 6:e27059.
15. Teufel R.J., Basco W.T., Simpson K.N. Cost effectiveness of an inpatient influenza immunization assessment and delivery program for children with asthma. J Hosp Med 2008, 3:134-141.
16. Trogdon J.G., Nurmagambetov T.A., Thompson H.F. The economic implications of influenza vaccination for adults with asthma. Am J Prev Med 2010, 39:403-410.
17. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:36-44.
18. Zaman K., Roy E., Arifeen S.E., Rahman M., Raqib R., Wilson E., et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med 2008, 359:1555-1564.
19. Carman W.F., Elder A.G., Wallace L.A., McAulay K., Walker A., Murray G.D., et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000, 355:93-97.
20. Potter J., Stott D.J., Roberts M.A., Elder A.G., Odonnell B., Knight P.V., et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997, 175:1-6.
21. Beutels P., Van Doorslaer E., Van Damme P., Hall J. Methodological issues and new developments in the economic evaluation of vaccines. Expert Rev Vaccine 2003, 2:649-660.
22. World Health Organization (WHO) WHO guide for standardization of economic evaluations of immunization programmes 2014, http://whqlibdoc.who.int/hq/2008/WHO_IVB_08.14_eng.pdf.
23. Cleemput I., Neyt M., Van De Sande S., Thiry N. Belgian guidelines for economic evaluations and budget impact analyses 2012, Federaal Kenniscentrum voor de Gezondheidszorg (KCE), Brussels, KCE Reports 183 C. 2nd ed.
24. Skowronski D.M., De Serres G. Is routine influenza immunization warranted in early pregnancy?. Vaccine 2009, 27:4754-4770.
25. Englund H., Campe H., Hautmann W. Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season. Epidemiol Infect 2013, 141:1807-1815.
26. Janjua N.Z., Skowronski D.M., De Serres G., Dickinson J., Crowcroft N.S., Taylor M., et al. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. J Infect Dis 2012, 205:1858-1868.
27. Kissling E., Valenciano M., Cohen J.M., Oroszi B., Barret A.S., Rizzo C., et al. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS ONE 2011, 6:e27622.
28. Skowronski D.M., Janjua N.Z., De Serres G., Winter A.L., Dickinson J.A., Gardy J.L., et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Clin Infect Dis 2012, 55:332-342.
29. Briggs A., Sculpher M., Claxton K. Decision modelling for health economic evaluation 2006, Oxford University Press, Oxford.
30. World Health Organization (WHO) Threshold values for intervention cost-effectiveness by region 2014, http://www.who.int/choice/costs/CER_levels/en/.
31. de Waure C., Veneziano M.A., Cadeddu C., Capizzi S., Specchia M.L., Capri S., et al. Economic value of influenza vaccination. Hum Vaccine Immunother 2012, 8:119-129.
32. Jit M., Newall A.T., Beutels P. Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies. Hum Vaccine Immunother 2013, 9:834-840.
33. Burls A., Jordan R., Barton P., Olowokure B., Wake B., Albon E., et al. Vaccinating healthcare workers against influenza to protect the vulnerable - is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine 2006, 24:4212-4221.
34. Treanor J.J., Talbot H.K., Ohmit S.E., Coleman L.A., Thompson M.G., Cheng P.Y., et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis 2012, 951-959.
35. Skowronski D.M., Tweed S.A., De Serres G. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?. J Infect Dis 2008, 197:490-502.
36. Englund J.A., Walter E., Black S., Blatter M., Nyberg J., Ruben F.L., et al. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study. Pediatr Infect Dis J 2010, 29:105-110.
37. Dushoff J., Plotkin J.B., Viboud C., Simonsen L., Miller M., Loeb M., et al. Vaccinating to protect a vulnerable subpopulation. PLoS Med 2007, 4:921-927.
38. Yamin D., Gavious A. Incentives' effect in influenza vaccination policy. Manage Sci 2013, 59:2667-2686.
39. Belgisch Centrum voor Farmacotherapeutische Informatie. Gecommentarieerd Geneesmiddelenrepertorium. http://www.bcfi.be/ggr/index.cfm%3FggrWelk=MAIN2014.
40. O'Brien B.J., Goeree R., Blackhouse G., Smieja M., Loeb M. Oseltamivir for treatment of influenza in healthy adults: pooled trial evidence and cost-effectiveness model for Canada. Value Health 2003, 6:116-125.
41. Bilcke J., Coenen S., Beutels P. Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all. PLOS ONE 2014, 9(7). 10.1371/journal.pone.0102634.